Low-Density Lipoprotein Cholesterol is Inversely Associated with All-Cause Mortality of Patients in the Coronary Care Unit

References

• Stram DO, Liu Y, Henderson KD, et al. Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study. Menopause. 2011;18(3):253–261. doi:10.1097/gme.0b013e3181f0839a
   PubMed Web of Science ®Google Scholar
• Mahmood SS, Levy D, Vasan RS, et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999–1008. doi:10.1016/S0140-6736(13)61752-3
   PubMed Web of Science ®Google Scholar
• Lee TH, Goldman L. The coronary care unit turns 25: historical trends and future directions. Ann Intern Med. 1988;108(6):887–894. doi:10.7326/0003-4819-108-6-887
   PubMed Web of Science ®Google Scholar
• Todo MC, Bergamasco CM, Azevedo PS, et al. Impact of coronary intensive care unit in treatment of myocardial infarction. Rev Assoc Med Bras. 2017;63(3):242–247. doi:10.1590/1806-9282.63.03.242
   PubMed Web of Science ®Google Scholar
• Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20(4):457–464. doi:10.1016/0002-9149(67)90023-9
   PubMed Web of Science ®Google Scholar
• Katz JN, Minder M, Olenchock B, et al. The genesis, maturation, and future of critical care cardiology. J Am Coll Cardiol. 2016;68(1):67–79. doi:10.1016/j.jacc.2016.04.036
   PubMed Web of Science ®Google Scholar
• Kasaoka S. Evolved role of the cardiovascular intensive care unit (CICU). J Intensive Care. 2017;5(1):72. doi:10.1186/s40560-017-0271-7
   PubMed Web of Science ®Google Scholar
• Teskey RJ, Calvin JE, McPhail I. Disease severity in the coronary care unit. Chest. 1991;100(6):1637–1642. doi:10.1378/chest.100.6.1637
   PubMed Web of Science ®Google Scholar
• Fye WB. Resuscitating a circulation abstract to celebrate the 50th anniversary of the coronary care unit concept. Circulation. 2011;124(17):1886–1893. doi:10.1161/CIRCULATIONAHA.111.033597
   PubMed Web of Science ®Google Scholar
• Alasnag M, Awan Z, Al Ghamdi A, Al Modaimeigh H, Al Shemiri M. Improvement initiative in LDL-C management in Saudi Arabia: a call to action. Int J Cardiol Heart Vasc. 2020;31:100667.
   PubMed Web of Science ®Google Scholar
• Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218–1240. doi:10.3390/nu5041218
   PubMed Web of Science ®Google Scholar
• Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation. 2000;101(2):207–213. doi:10.1161/01.CIR.101.2.207
   PubMed Web of Science ®Google Scholar
• Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2017;38(32):2459–2472. doi:10.1093/eurheartj/ehx144
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2017 focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American college of cardiology task force on expert consensus decision pathways. J Am Coll Cardiol. 2017;70(14):1785–1822.
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;139(25):e1082–e1143.
   PubMed Web of Science ®Google Scholar
• Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188.
   PubMed Web of Science ®Google Scholar
• Johnson AEW, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3(1):160035. doi:10.1038/sdata.2016.35
   PubMed Web of Science ®Google Scholar
• Sun H, Que J, Peng Y, et al. The neutrophil-lymphocyte ratio: a promising predictor of mortality in coronary care unit patients — a cohort study. Int Immunopharmacol. 2019;74:105692. doi:10.1016/j.intimp.2019.105692
   PubMed Web of Science ®Google Scholar
• Jaddoe VW, de Jonge LL, Hofman A, et al. First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study. BMJ. 2014;348(jan23 1):g14. doi:10.1136/bmj.g14
   PubMed Web of Science ®Google Scholar
• Zhu L, She Z-G, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068–1077.e3. doi:10.1016/j.cmet.2020.04.021
   PubMed Web of Science ®Google Scholar
• Katzmarzyk PT, Church TS, Craig CL, et al. Sitting time and mortality from all causes, cardiovascular disease, and cancer. Med Sci Sports Exerc. 2009;41(5):998–1005. doi:10.1249/MSS.0b013e3181930355
   PubMed Web of Science ®Google Scholar
• Garcia M, Mulvagh SL, Bairey Merz CN, et al. Cardiovascular disease in women: clinical perspectives. Circ Res. 2016;118(8):1273–1293. doi:10.1161/CIRCRESAHA.116.307547
   PubMed Web of Science ®Google Scholar
• Peng Y, Guan X, Wang J, et al. Red cell distribution width is correlated with all-cause mortality of patients in the coronary care unit. J Int Med Res. 2020;48(7):300060520941317. doi:10.1177/0300060520941317
   PubMed Web of Science ®Google Scholar
• Rhoads JP, Major AS. How oxidized low-density lipoprotein activates inflammatory responses. Crit Rev Immunol. 2018;38(4):333–342. doi:10.1615/CritRevImmunol.2018026483
   PubMed Web of Science ®Google Scholar
• Feingold KR, Funk JL, Moser AH, et al. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect Immun. 1995;63(5):2041–2046. doi:10.1128/iai.63.5.2041-2046.1995
   PubMed Web of Science ®Google Scholar
• Bosmann M, Ward PA. The inflammatory response in sepsis. Trends Immunol. 2013;34(3):129–136. doi:10.1016/j.it.2012.09.004
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Fraunberger P, Schaefer S, Werdan K, et al. Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin Chem Lab Med. 1999;37(3):357–362. doi:10.1515/CCLM.1999.059
   PubMed Web of Science ®Google Scholar
• Golucci A, Marson FAL, Ribeiro AF, et al. Lipid profile associated with the systemic inflammatory response syndrome and sepsis in critically ill patients. Nutrition. 2018;55–56:7–14. doi:10.1016/j.nut.2018.04.007
   PubMed Web of Science ®Google Scholar
• Netea MG, Demacker PN, Kullberg BJ, et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest. 1996;97(6):1366–1372. doi:10.1172/JCI118556
   PubMed Web of Science ®Google Scholar